While we measured key biomarkers, the absence of data on adiponectin levels or direct measures of insulin resistance (e.g., HOMA-IR) prevents a deeper mechanistic exploration of the observed lipid profile and IGF-system dysregulation. This evidence concerns the gene ADIPOQ and Insulin resistance.